Dr. Lingzhi Zhong PLA General Hospital, China.
Dr. Lingzhi Zhong is an Assistant Research Fellow and Lecturer at the PLA General Hospital 🏥. She holds a Ph.D. in Pathology and Physiology from Jilin University 🎓. Her research specializes in tissue repair and regenerative medicine 🧬. With over ten peer-reviewed publications, several patents, and editorial roles, she has made remarkable strides in wound healing innovations 💡. Dr. Zhong is also a member of the Microcirculation Committee and continues to drive impactful biomedical research with passion and precision 🔬✨.
Professional Profile
Orcid Profile
🎓 Early Academic Pursuits
Lingzhi Zhong began her academic journey with a Ph.D. in Pathology and Physiology from Jilin University School of Basic Medicine. During her formative years, she cultivated a strong foundation in medical sciences, with a growing interest in tissue repair and regenerative medicine. Her rigorous academic training laid the groundwork for a prolific research career that would later evolve into impactful scientific contributions.
💼 Professional Endeavors
Dr. Zhong currently serves as an Assistant Research Fellow and Lecturer at the Department of Basic Medicine, PLA General Hospital. With over a decade of research experience, she is actively involved in the scientific community, both as a lecturer and investigator. Her professional trajectory also includes editorial roles, contributing as a board member and associate editor for esteemed academic publications. Her academic service underscores her dedication to both teaching and research leadership.
🔬 Contributions and Research Focus On Medicine
Dr. Zhong’s research centers around wound healing, tissue regeneration, and anti-scarring innovations. One of her notable breakthroughs includes the reprogramming of fibroblasts into endothelial cells using forskolin, a discovery funded by the Youth Project of the National Natural Science Foundation of China. She has also explored the potential of arsenic compounds in inhibiting scar formation—an unprecedented approach in wound repair research. Her multi-faceted innovations bridge chemistry, biology, and medicine.
🌍 Impact and Influence
Her work has made a tangible impact on regenerative medicine, advancing strategies for scar reduction and chronic wound healing. The development of composite dressings and chitosan-based therapeutics reflects her commitment to clinical translation and improved patient outcomes. She has co-authored over ten SCI-indexed publications, each contributing to a better understanding of biological healing processes and therapeutic design.
🏆 Awards and Honors
Dr. Zhong has earned recognition for her pioneering research in regenerative medicine and wound care. Her nomination for the Best Researcher Award underlines her innovative edge and dedication to biomedical science. Her editorial appointments and participation in professional societies like the Microcirculation Committee of the Society of Integrated Traditional Chinese and Western Medicine further reinforce her respected standing in the scientific community.
📚 Books, Patents, and Innovation
Her contributions extend beyond journal articles. Dr. Zhong is currently co-authoring a book titled “Progress in Life Sciences”. She also holds three patents in advanced biomedical technologies:
-
Composite dressing for skin healing
-
Chemical induction of dermal fibroblasts
-
Chitosan-taurine microbeads for scar reduction
These innovations demonstrate her translational research impact, turning lab discoveries into therapeutic applications.
🚀 Legacy and Future Contributions
Lingzhi Zhong is at the forefront of translational regenerative medicine. Her work continues to inspire new methods for scar-free healing, and she remains dedicated to developing novel bioactive delivery systems. With continued research, editorial leadership, and interdisciplinary collaboration, Dr. Zhong is poised to make lasting contributions to science and human health.
📚Publications Top Notes
-
🧴 Forskolin-loaded carboxymethyl chitosan and silk nanofiber hydrogels composite scaffolds improve skin regeneration
International Journal of Biological Macromolecules, 2025
-
🧬 Chitosan-taurine nanoparticles cross-linked carboxymethyl chitosan hydrogels facilitate both acute and chronic diabetic wound healing
International Journal of Biological Macromolecules, 2024
-
🧠 Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects
Stem Cell Research & Therapy, 2022
-
🐷 Characterization of the Skin Bacteriome and Histology Changes in Diabetic Pigs
The International Journal of Lower Extremity Wounds, 2022
-
🌿 Promotive effects of four herbal medicine ARCC on wound healing in mice and human
Health Science Reports, 2022
-
🔬 A New Target of the Four-Herb Chinese Medicine for Wound Repair Promoted by Mitochondrial Metabolism Using Protein Acetylation Analysis
Medical Science Monitor, 2022
-
🔥 Macrophage Related Chronic Inflammation in Non-Healing Wounds
Frontiers in Immunology, 2021
-
🧫 Biological approaches for hypertrophic scars
International Wound Journal, 2020
-
🩹 Chitosan/LiCl composite scaffolds promote skin regeneration in full-thickness loss
Science China Life Sciences, 2020
-
🧪 Sustained release of inhibitor from bionic scaffolds for wound healing and functional regeneration
Biomaterials Science, 2020
-
💧 Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives
Stem Cells International, 2019
-
🕸️ Concentrated Conditioned Medium-Loaded Silk Nanofiber Hydrogels with Sustained Release of Bioactive Factors To Improve Skin Regeneration
ACS Applied Bio Materials, 2019
-
🚫 Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through NFE2L2 and Smad2/3
Journal of Cellular Physiology, 2019
-
🧪 Comparative Proteomic Analysis of the Effect of the Four-Herb Chinese Medicine ANBP on Promoting Mouse Skin Wound Healing
The International Journal of Lower Extremity Wounds, 2017
-
🧠 Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 via NFE2L2
International Journal of Medical Sciences, 2015
-
🦴 Heme oxygenase-1 silencing increases sensitivity of osteosarcoma MG63 cells to arsenic trioxide
Molecular and Cellular Biochemistry, 2014